{"url_path":"/sec/nvno/8-k/2026-07-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1661053/0001493152-26-033193-index.html","accession_number":"0001493152-26-033193","cik":"0001661053","ticker":"NVNO","issuer_name":"enVVeno Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1661053/0001493152-26-033193-index.html","primary_entity_key":"0001661053","primary_entity_name":"enVVeno Medical Corp"},"word_count":92,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\nSet\nforth below is a list of Exhibits included as part of this Current Report:\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n99.1\n \n[Investor Presentation issued by enVVeno Medical Corporation](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**ENVVENO\nMEDICAL CORPORATION**\n\n \n \n\nDated:\nJuly 14, 2026\n*/s/\nRobert A. Berman*\n\n \nRobert\nA. Berman\n\n \nChief\nExecutive Officer"}